MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
618
Beneficiaries
—
Total drug cost
$5.0M
Distinct drugs
21
Brand share
85.8%
Top prescribed drugs
Methotrexate Sodium78 claims
Ustekinumab70 claims
Ofatumumab65 claims
Adalimumab37 claims
Glatiramer Acetate37 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
CROSS-REFERENCE